SCYNEXIS INC SCYX
- BREXAFEMME — Vulvovaginal Candidiasis Approved
- SCY-247 — Invasive Candidiasis Phase 1
- SCY-247 — Invasive Candidiasis Phase 1
- SCY-247 — Invasive Fungal Infections Preclinical
Home › Targets › glucan synthase
Companies with an active program directed at glucan synthase.